kinetic study on the reactions of platinum drugs with glutathione

kinetic study on the reactions of platinum drugs with glutathione Schematic representation A: Mode of action of platinum-based drug Recent Advances of Platinum‐Based Anticancer – A cisplatin-based platinum(IV) prodrug containing

Name: kinetic study on the reactions of platinum drugs with glutathione Schematic representation A: Mode of action of platinum-based drug Recent Advances of Platinum‐Based Anticancer – A cisplatin-based platinum(IV) prodrug containing
Brand: ldesquadrias.com.br
SKU: 21049031138
Price: 22.77 USD
Availability: InStock
Rating: 4.5949 (12 reviews)

A cisplatin based platinum(IV) prodrug containing a glutathione s transferase inhibitor to reverse cisplatin resistance in non small cell lung cancer ScienceDirect kinetic study on the reactions of platinum drugs with glutathione A platinum(IV) prodrug strategy to overcome glutathione based oxaliplatin resistance Frontiers Glutathione responsive and exhausting The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs PMC Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Influence of chemical structure and mechanism of hydrolysis on pharmacological activity and toxicological profile of approved platinum drugs Combination strategies of platinum based drugs (cisplatin or Download Scientific Diagram

SKU: 21049031138 · From ldesquadrias.com.br

4.6

USD22.77 USD49.77

Pay in 4 interest-free payments of $5.69 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

S.BernsC

kinetic study on the reactions of platinum drugs with glutathione Schematic representation A: Mode of action of platinum-based drug Recent Advances of PlatinumBased Anticancer A cisplatin-based platinum(IV) prodrug containing

[78] found that cells were highly sensitive to peroxide-induced ferroptosis by replacing selenocysteine in GPX4 with cysteine, demonstrating the importance of selenium for GPX4 to function as an antioxidant against ferroptosis

If human trials with the compound show safety and efficacy, NNMT inhibitors like 5-amino-1MQ could serve to prevent and/or slow age-related muscle deterioration in humans, a tantalizing prospect